Antheia Announces New Financing and Plans to Construct Pilot Plant Facility for Biomanufacturing
![Press-Release-Thumbnail](https://antheia.bio/wp-content/uploads/2024/01/Press-Release-Thumbnail_Compressed-1024x768.webp)
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced $40 million in venture debt financing from Oxford Finance LLC and Silicon Valley Bank, alongside plans to construct a new pilot scale biomanufacturing facility.
Syn Bio Companies Put the Earth into Focus
![](https://antheia.bio/wp-content/uploads/2022/04/javier-miranda-Jn2EaLLYZfY-unsplash-1.png)
While some synthetic biology companies are using biology to improve our food, clothes, and medicine, others are turning their attention to helping the Earth.
Biomanufacturing draws hundreds of millions in investments
![Biomanufacturing draws hundreds of millions in investments](https://antheia.bio/wp-content/uploads/2021/07/Industrial-Fermentation-2-1-jpg.webp)
Fundraising at Bota Bio, Genomatica, and Antheia signals an upshift for commercial-scale synthetic biology…
Antheia Raises $73M in Series B
![](https://antheia.bio/wp-content/uploads/2021/07/MaisonAntheia-197-1-jpg.webp)
Antheia, a Menlo Park CA-based synthetic biology company, raised $73M in Series B funding. The round was led by Viking Global Investors with participation from Sherpalo Ventures and Hillspire…
Antheia Secures $73M in Series B
![](https://antheia.bio/wp-content/uploads/2021/07/Antheia-employees-jpg.webp)
Antheia, a synthetic biology company working to develop plant-inspired medicine, has officially secured a fresh $73 million in Series B funding…
Antheia raises $73 million for drugs from reprogrammed yeast
![](https://antheia.bio/wp-content/uploads/2021/07/MaisonAntheia-147-1-jpg.webp)
Antheia, a synthetic biology company cofounded and led by Stanford University bioengineer Christina Smolke, has raised $73 million in series B financing…
The Funded: Accel and three unicorns score jumbo deals at midweek
![](https://antheia.bio/wp-content/uploads/2021/07/pexels-karolina-grabowska-4386471-1.png)
Antheia Inc., Menlo Park, $73 million: Viking Global Investors led the Series B funding of this company that’s making plant-based medicines using synthetic biology. Sherpalo Ventures and Eric Schmidt’s Hillspire…
Money on the Move: June 30 – July 6
![](https://antheia.bio/wp-content/uploads/2021/07/engin-akyurt-WFvvQj48KeA-unsplash-1.png)
Synthetic biology startup Antheia raised $73 million in Series B financing to support the company’s efforts to bring its first plant-based medicine to market and support the production of necessary active…
Startup using yeast to make drug components raises $73M
![](https://antheia.bio/wp-content/uploads/2023/05/Startup-using-yeast-to-make-drug.jpg)
The idea: A California company producing active pharmaceutical ingredients with engineered yeast raised $73 million to bring its first product to market…
Top 10 Synthetic Biology Companies
![](https://antheia.bio/wp-content/uploads/2021/07/ashraful-islam-pRt3JVYlJho-unsplash-1.png)
Any doubts about synthetic biology’s attractiveness to investors were likely shattered during the first quarter, when investors pumped $4.6 billion into such companies—more than four times the $904.7 million invested…